William C Weldon Selected Research

Poliomyelitis (Polio)

7/2021	Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.
1/2021	A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.
1/2021	Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
1/2021	Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
11/2020	Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
8/2020	Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan.
1/2020	Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
10/2019	Poliopolis: pushing boundaries of scientific innovations for disease eradication.
1/2019	The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
1/2019	Extended delivery of vaccines to the skin improves immune responses.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William C Weldon Research Topics

Disease

41	Poliomyelitis (Polio) 07/2021 - 01/2014
5	Rabies (Hydrophobia) 03/2006 - 04/2005
4	Infections 01/2020 - 04/2005
3	Malnutrition (Nutritional Deficiencies) 01/2018 - 06/2015
3	Human Influenza (Influenza) 01/2012 - 09/2010
2	acute flaccid myelitis 01/2022 - 10/2020
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Persistent Infection 01/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Growth Disorders 09/2017
1	Vaccine-Preventable Diseases 01/2016
1	Intussusception 11/2015
1	Enterovirus Infections 08/2015
1	Paralysis (Palsy) 08/2015
1	Vaccinia 07/2005

Drug/Important Bio-Agent (IBA)

34	VaccinesIBA 01/2022 - 07/2005
13	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2022 - 09/2014
11	AntibodiesIBA 01/2021 - 07/2005
11	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2021 - 04/2015
5	Poliovirus VaccinesIBA 01/2021 - 12/2015
5	Neutralizing AntibodiesIBA 01/2021 - 01/2014
5	Immunoglobulin A (IgA)IBA 10/2018 - 01/2014
4	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 04/2005
2	CytokinesIBA 10/2020 - 01/2012
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 03/2006 - 07/2005
1	Insulin (Novolin)FDA Link 01/2021
1	AutoantibodiesIBA 01/2021
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2021
1	Fibroins (Fibroin)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Capsid Proteins (Capsid Protein)IBA 01/2020
1	Combined VaccinesIBA 10/2018
1	AntigensIBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2015
1	ImmunosorbentsIBA 01/2014
1	EnzymesIBA 01/2014
1	Imiquimod (Aldara)FDA LinkGeneric 01/2012
1	LigandsIBA 01/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2012
1	Subunit VaccinesIBA 01/2012
1	Hemagglutinins (Hemagglutinin)IBA 09/2010
1	Synthetic Vaccines (Recombinant Vaccines)IBA 07/2005
1	Combined Antibody TherapeuticsIBA 07/2005
1	Glycoproteins (Glycoprotein)IBA 07/2005
1	Rabies Vaccines (Rabies Vaccine)FDA Link 04/2005

Therapy/Procedure

1	Intradermal Injections 01/2019
1	Therapeutics 08/2015